TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR
TETROUS, INC., a leading regenerative medicine company today announced that it has completed the first surgical cases using EnFix TAC™, its latest product that expands its line of EnFix™ implants to cover every surgical technique for rotator cuff repair. The…
eXeX & AdventHealth Surgery Center Innovation Tower Pioneer Use of Apple Vision Pro in Joint Replacement Surgery
eXeX, a leader in artificial intelligence enhanced surgical logistics software, has achieved a world first by successfully utilizing the Apple Vision Pro in organizing and managing a Reverse Total Shoulder Arthroplasty. This marks the first-ever use of Apple’s spatial computing…
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced its partner, DEKA Research & Development Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the innovative twiist™ Automated Insulin Delivery (AID)…
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes (“T1D”), today announced the submission of the study protocol to the FDA…
St. Elizabeth Healthcare First in Kentucky to Implant New Device To Treat Abnormal Heart Rhythm
Doctors with the Florence Wormald Heart & Vascular Institute at St. Elizabeth Healthcare are the first in Kentucky and the Greater Cincinnati region to implant the Aurora EV-ICD™ system — a new device to treat fast or irregular heartbeats and prevent sudden cardiac arrest. J. Christian Hays, MD,…
NUTEX HEALTH LAUNCHES INNOVATIVE PSYCHIATRIC SERVICES AT TEXAS HOSPITAL
Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that SE Texas ER & Hospital…
NYU Langone Health ranked No. 1 in the Nation for Quality and Patient Safety
NYU Langone Health has once again been named No. 1 in the nation for quality and patient safety by Vizient, Inc., a leading healthcare performance improvement organization that determines its rankings based on mortality and infection rates, patient experience scores,…
RedHill Announces FDA sNDA Approval for Talicia®
RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced the U.S. Food and Drug Administration’s (FDA) approval of its supplemental new drug application (sNDA) for Talicia[3], allowing a change to a more flexible three times…
European Medicines Agency Validates Type II Variation for Astellas’ XTANDI® (enzalutamide) for Treatment of Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the European Medicines Agency (EMA) has validated its Type II variation for XTANDI® (enzalutamide) for the treatment of patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC; also…
National Jewish Health Appoints Evan Zucker as Chair of Board of Directors
Evan Zucker has been named Chair of the National Jewish Health Board of Directors. He succeeds Steven D. Kris, who has been board chair since January 2020, and will continue to serve as a member of the board and executive…
